JP2024532596A5 - - Google Patents

Info

Publication number
JP2024532596A5
JP2024532596A5 JP2024536342A JP2024536342A JP2024532596A5 JP 2024532596 A5 JP2024532596 A5 JP 2024532596A5 JP 2024536342 A JP2024536342 A JP 2024536342A JP 2024536342 A JP2024536342 A JP 2024536342A JP 2024532596 A5 JP2024532596 A5 JP 2024532596A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
recombinant protein
vector
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024536342A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532596A (ja
JP7687643B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/114516 external-priority patent/WO2023025193A1/zh
Publication of JP2024532596A publication Critical patent/JP2024532596A/ja
Publication of JP2024532596A5 publication Critical patent/JP2024532596A5/ja
Application granted granted Critical
Publication of JP7687643B2 publication Critical patent/JP7687643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024536342A 2021-08-25 2022-08-24 神経成長因子突然変異体の組換えタンパク質及びその使用 Active JP7687643B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110981721 2021-08-25
CN202110981721.5 2021-08-25
PCT/CN2022/114516 WO2023025193A1 (zh) 2021-08-25 2022-08-24 神经生长因子突变体重组蛋白及其应用

Publications (3)

Publication Number Publication Date
JP2024532596A JP2024532596A (ja) 2024-09-05
JP2024532596A5 true JP2024532596A5 (cg-RX-API-DMAC7.html) 2024-09-19
JP7687643B2 JP7687643B2 (ja) 2025-06-03

Family

ID=82862610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536342A Active JP7687643B2 (ja) 2021-08-25 2022-08-24 神経成長因子突然変異体の組換えタンパク質及びその使用

Country Status (5)

Country Link
US (1) US20250009846A1 (cg-RX-API-DMAC7.html)
EP (1) EP4375367B1 (cg-RX-API-DMAC7.html)
JP (1) JP7687643B2 (cg-RX-API-DMAC7.html)
CN (1) CN114933657B (cg-RX-API-DMAC7.html)
WO (1) WO2023025193A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114933657B (zh) * 2021-08-25 2024-02-02 上海交通大学医学院 神经生长因子突变体重组蛋白及其应用
WO2024189146A1 (en) * 2023-03-15 2024-09-19 Versameb Ag Rna encoding a protein
WO2025130564A1 (zh) * 2023-12-20 2025-06-26 广州市恒诺康医药科技有限公司 编码神经生长因子(NGF)的mRNA及其组合物和应用
WO2025184345A1 (en) * 2024-02-27 2025-09-04 Ohio State Innovation Foundation Methods and compositions for treating neuropathy
EP4623927A1 (en) 2024-03-27 2025-10-01 Dompe' Farmaceutici SpA Ngf for use in the prevention or treatment of motor impairment caused by neonatal hypoxic-ischemic encephalopathy

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1709161T3 (da) * 2004-01-19 2009-01-26 Nsgene As Humane terapeutiske celler, som udskiller nervevækstfaktor
EP2048237A1 (en) * 2007-10-05 2009-04-15 Avir Green Hills Biotechnology Research Development Trade Ag Replication deficient Influenza virus for the expression of heterologous sequences
US8236527B2 (en) * 2008-03-14 2012-08-07 Humanzyme Limited Recombinant production of authentic human proteins using human cell expression systems
BRPI0915142A8 (pt) * 2008-06-12 2018-01-02 Syntaxin Ltd Polipeptídeos, ácido nucleico e usos dos mesmos
US20110312872A1 (en) * 2008-12-22 2011-12-22 Universität Regensburg Norrin in the treatment of diseases associated with an increased tgf-beta activity
CA2750027C (en) * 2009-01-23 2020-11-10 Nsgene A/S Improved cell lines and their use in encapsulated cell biodelivery
CN103476791A (zh) * 2011-01-11 2013-12-25 菲特治疗公司 新型wnt组合物和该组合物的治疗用途
WO2012170452A2 (en) * 2011-06-06 2012-12-13 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
CN106008722B (zh) * 2016-05-13 2019-10-15 未名生物医药有限公司 一种重组β-hNGF-Fc融合蛋白、制备方法及用途
CN108178798B (zh) * 2016-12-08 2021-03-30 苏州方德门达新药开发有限公司 pH工程化的NGF抗体及其医药用途
CN110869386A (zh) * 2017-02-10 2020-03-06 维维巴巴公司 重组神经生长因子的组合物和方法
GB201705484D0 (en) * 2017-04-05 2017-05-17 Quethera Ltd Genetic construct
CN108314723A (zh) * 2018-01-11 2018-07-24 温州医科大学 一种人源突变型神经生长因子及其制备方法和应用
CN108610398B (zh) * 2018-01-15 2020-08-11 武汉海特生物制药股份有限公司 一段功能序列及在分泌蛋白表达中的应用
KR20220142471A (ko) * 2020-02-14 2022-10-21 유니버시티 오브 워싱턴 폴리펩타이드 및 그 용도
CN112794893A (zh) * 2021-01-29 2021-05-14 华中农业大学 一种捻转血矛线虫Hc-H11-2重组蛋白的构建方法及其应用
CN114933657B (zh) * 2021-08-25 2024-02-02 上海交通大学医学院 神经生长因子突变体重组蛋白及其应用

Similar Documents

Publication Publication Date Title
JP7374254B2 (ja) 調節性ポリヌクレオチド
CN1286981C (zh) 表达人类cyp2j2反义基因的重组腺相关病毒及其制备方法
JP2021100435A (ja) 調節性ポリヌクレオチド
AU2014329452A1 (en) Polynucleotides encoding low density lipoprotein receptor
WO2023020574A1 (en) Engineered adar-recruiting rnas and methods of use thereof
WO2023104028A1 (zh) 非编码rna介导的神经性疾病治疗
US20250257368A1 (en) In vitro assembly of anellovirus capsids enclosing rna
CN108251420A (zh) 抑制人和动物中CTGF基因表达的siRNA、包含其的组合物及其应用
TW202223095A (zh) 串聯指環病毒構築體
CN110331147A (zh) 一种mRNA的制备方法及其在肿瘤治疗中的应用
CN114599789A (zh) 人工合成mRNA及其利用
CN115896104A (zh) 一种去靶向神经元递送的工程化mRNA及其制备方法和应用
US6830929B1 (en) In vitro construction of SV40 viruses and pseudoviruses
WO2026091523A1 (zh) 一种靶向胶质母细胞瘤的siRNA及其应用
EP4125933A1 (en) Compositions and methods for treating cystic fibrosis
CN108866058A (zh) 靶向KRAS的siRNA及其在制备胰腺癌治疗药物中的应用
CN114807127A (zh) 用于结缔组织生长因子的小干扰rna及其应用
KR102918706B1 (ko) mRNA 백신 및 치료제의 제조를 위한 변형된 RNA
RU2852567C2 (ru) Сконструированный полипептид человеческого фактора VIII (hFVIII) с повышенной коагулирующей активностью, фрагмент выделенной нуклеиновой кислоты, вектор экспрессии (варианты), фармацевтическая композиция для лечения гемофилии A и способ ее лечения
CN101934069A (zh) 脑红蛋白在促进神经元突起生长中的应用
CN118754947B (zh) 一种多肽及其多肽复合物纳米粒、核酸疫苗和应用
CN114042079B (zh) Rna在治疗扩张性心肌病和心肌纤维化中的应用
JP5789927B2 (ja) 放射線照射コラーゲン様ペプチドを用いた核酸導入法
CN1948482B (zh) 抑制人RabJ基因表达的反义寡核苷酸序列及其应用
WO2025110115A1 (ja) Cxcl12 rna配列に基づく新規二本鎖rna及びその利用